ESR1 and breast neoplasm: Most of the existing studies have been absorbed in the prognosis of breast tumor patients with a single negative ER or PR status or stratified analysis of the expression of a single receptor [14, 15], but there are few clinical studies on the combined stratification of the expression of ER and PR.